Jeremy Grantham Teva Pharmaceutical Industries LTD Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$31.8 Billion
Q2 2025

A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 15,337 shares of TEVA stock, worth $300,758. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,337

Holding current value

$300,758

% of portfolio

0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$12.82 - $18.15 $196,620 - $278,366	15,337 New	15,337 $257,000
Q3 2024 Nov 13, 2024	SELL	$15.81 - $18.96 $32.2 Million - $38.6 Million	-2,036,723 Reduced 99.09%	18,792 $338,000
Q2 2024 Aug 13, 2024	SELL	$12.78 - $17.4 $4.83 Million - $6.57 Million	-377,752 Reduced 15.52%	2,055,515 $33.4 Million
Q1 2024 May 14, 2024	SELL	$10.67 - $14.43 $9.04 Million - $12.2 Million	-846,794 Reduced 25.82%	2,433,267 $34.3 Million
Q4 2023 Feb 13, 2024	SELL	$8.12 - $10.63 $1.5 Million - $1.96 Million	-184,146 Reduced 5.32%	3,280,061 $34.2 Million
Q3 2023 Nov 13, 2023	SELL	$7.48 - $10.7 $640,108 - $915,663	-85,576 Reduced 2.41%	3,464,207 $35.3 Million
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $2.17 Million - $2.86 Million	301,583 Added 9.28%	3,549,783 $26.7 Million
Q1 2023 May 12, 2023	SELL	$8.36 - $11.37 $4.2 Million - $5.71 Million	-502,100 Reduced 13.39%	3,248,200 $28.7 Million
Q4 2022 Feb 13, 2023	BUY	$7.95 - $9.48 $3.48 Million - $4.15 Million	437,400 Added 13.2%	3,750,300 $34.2 Million
Q3 2022 Nov 10, 2022	SELL	$6.86 - $11.95 $1.04 Million - $1.81 Million	-151,800 Reduced 4.38%	3,312,900 $26.7 Million
Q2 2022 Aug 12, 2022	SELL	$7.38 - $10.4 $84,132 - $118,560	-11,400 Reduced 0.33%	3,464,700 $26.1 Million
Q1 2022 May 13, 2022	BUY	$7.33 - $9.39 $5.13 Million - $6.58 Million	700,500 Added 25.24%	3,476,100 $32.6 Million
Q4 2021 Feb 11, 2022	SELL	$7.9 - $10.19 $237,790 - $306,719	-30,100 Reduced 1.07%	2,775,600 $22.2 Million
Q3 2021 Nov 12, 2021	BUY	$8.38 - $10.18 $2.12 Million - $2.57 Million	252,800 Added 9.9%	2,805,700 $27.3 Million
Q2 2021 Aug 12, 2021	BUY	$9.9 - $11.56 $5.53 Million - $6.46 Million	559,000 Added 28.04%	2,552,900 $25.3 Million
Q1 2021 May 13, 2021	BUY	$10.34 - $12.81 $1.84 Million - $2.28 Million	178,300 Added 9.82%	1,993,900 $23 Million
Q4 2020 Feb 12, 2021	BUY	$8.61 - $11.04 $15.6 Million - $20 Million	1,815,600 New	1,815,600 $17.5 Million
Q1 2019 May 14, 2019	SELL	$15.58 - $20.01 $233,700 - $300,150	-15,000 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$14.59 - $23.84 $218,850 - $357,600	15,000 New	15,000 $231,000
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $777,114 - $946,485	-36,900 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$16.77 - $24.71 $618,813 - $911,799	36,900 New	36,900 $897,000

Others Institutions Holding TEVA

# of Institutions

659

Shares Held

659M

Call Options Held

30.1M

Put Options Held

16.4M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $21.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account